Breast Cancer Canada is proud to announce our second annual Precision Oncology Research Grant recipients. Researchers from across Canada were invited to submit projects last December for funding consideration in 2023. The selected projects focus on one of the four divisions of precision oncology research identified by the Scientific Advisory Committee: basic science, screening and detection, personalized treatment, and patient-reported outcomes. All projects must also include an artificial intelligence (AI) component and a patient advocate actively participating in the research.
The following are the researchers that have been selected by Breast Cancer Canada for funding:
$75,000 |
Dr. Saima Hassan Centre de Recherche de Centre Hospitalier de l’Université de Montréal (CRCHUM) |
Disentangling the immune landscape to predict response to immunotherapy and PARP inhibition in breast cancer |
$75,000 |
Dr. Katarzyna Jerzak Sunnybrook Odette Cancer Centre |
Identifying microRNA predictive biomarkers for breast to brain metastasis |
$75,000 |
Dr. Joanne Kotsopoulos Women’s College Hospital University of Toronto |
Improving long-term outcomes following the diagnosis and treatment of BRCA1-associated breast cancer |
$75,000 |
Dr. Hermann Nabi Quebec City University Hospital Research Centre |
Personalized risk-stratified breast cancer follow-up care |
$50,000 |
Dr. Luc Sabourin Ottawa Hospital Research Institute |
Targeting Sox10 activity in HER2+ breast cancers |
$50,000 |
Dr. Mohammad Reza Akbari Women’s College Hospital University of Toronto |
Gene expression profiling in young-onset breast cancer patients with ER+/HER2- breast cancer (prognosis and chemotherapy) |
Driven by their vision to end breast cancer, Breast Cancer Canada is committed to funding research projects that will directly impact Canadian patients, focusing on the rapid movement of research findings from lab bench to bedside. Grant recipient Dr. Katarzyna Jerzak, researcher at Sunnybrook Odette Cancer Centre will use her funding for the microRNA biomarkers. Dr. Jerzak and her team will focus on identifying predictive biomarkers for brain metastasis in patients with breast cancer.
Breast Cancer Canada’s Scientific Advisory Committee led the selection process and is committed to listening to breast cancer patients. All funded project teams are required to include a breast cancer patient advocate or a local breast cancer advocacy group as part of their research.
For more information on Breast Cancer Canada and the research projects we fund, please visit, breastcancerprogress.ca.
About Breast Cancer Canada
Breast Cancer Canada is a national charity dedicated to saving lives through breast cancer research. With a focus on precision oncology (personalized care), it is the only national breast cancer organization in Canada that has a clear mandate to raise money for research. The organization receives no government funding, meaning all research is funded through the generosity of donors. For more information visit, breastcancerprogress.ca.
—
Media
Lindsay Silverberg
Senior Account Manager
lindsay@talkshopmedia.com